Accelerating drug development
using pooled functional screening on a consumable product
The problem
Libraries can exceed a million variants, but function is still measured using arrayed assays a few hundred or thousand wells at a time. AI widens the gap by designing more candidates, not fewer.
Advemto cartridge technology
From library to sequence-linked function in five steps.
Library prepared off the cartridge, single cells intact.
Cells settle into wells, each with its own address.
Live-cell function, read across every well at once.
Hits pooled; every read resolves back to its well.
Every cell’s function indexed to its sequence.
Where it fits
Screen antibody, bispecific, peptide, CAR-T and TCR candidates on function, then sequence the ones that work.
Test mRNA constructs, UTRs, antigen and neoantigen candidates side by side, at library scale.
Not tied to one modality. Use it wherever function needs to be read cell by cell, including cell–cell interactions.
Milestones
Early access
We’re inviting a small number of programmes to work with us from mid-2027. If functional screening at library scale is a bottleneck for you, we’d like to hear about it.